Castration resistant prostate cancer treatment Market 2018 Global Share, Trend, Segmentation and Forecast to 2021

“castration resistant prostate cancer treatment Market”
The analysts forecast the global castration-resistant prostate cancer treatment market to grow at a CAGR of 9.01% during the period 2017-2021.

 

 

Global castration resistant prostate cancer treatment Market

WiseGuyRerports.com Presents “Global castration resistant prostate cancer treatment market 2017-2021” New Document to its Studies Database. The Report Contain 87 Pages With Detailed Analysis.

Description

Prostate cancer is also known as carcinoma of the prostate is cancer of the prostate gland that affects only the male population. It is a slow progressive disease. CRPC is an inveterate stage of prostate cancer, in which almost 90% of individuals develop metastases, specifically in the skeleton. The major therapies involved in the treatment of CRPC are hormonal therapy and chemotherapy.

The analysts forecast the global castration-resistant prostate cancer treatment market to grow at a CAGR of 9.01% during the period 2017-2021.

Covered in this report 
The report covers the present scenario and the growth prospects of the global castration resistant prostate cancer treatment market for 2017-2021. To calculate the market size, the report considers sales of branded, generic, and off-label drugs.

 

Get sample Report @ https://www.wiseguyreports.com/sample-request/1563884-global-castration-resistant-prostate-cancer-treatment-market-2017-2021

 

The market is divided into the following segments based on geography: 
• Americas 
• APAC 
• EMEA

The Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors 
• Astellas Pharma 
• Johnson & Johnson 
• Sanofi 
• Valeant

Other prominent vendors 
• Active Biotech 
• Advaxis 
• ANI Pharmaceuticals 
• Athenex 
• Bavarian Nordic 
• Bayer 
• Bristol-Myers Squibb 
• CureVac 
• GlaxoSmithKline 
• Innocrin Pharmaceutical 
• Merck 
• Myovant Sciences 
• Northwest Biotherapeutics 
• OncoGenex Pharmaceuticals 
• Oncolytics Biotech 
• Orion 
• Sotio 
• Madrigal Pharmaceuticals) 
• Takeda Pharmaceutical 
• Teva Pharmaceutical Industries

Market driver 
• Physician’s preference toward hormonal therapy 
• For a full, detailed list, view our report

Market challenge 
• High cost of treatment 
• For a full, detailed list, view our report

Market trend 
• Increasing consolidation in cancer treatment market 
• For a full, detailed list, view our report

Key questions answered in this report 
• What will the market size be in 2021 and what will the growth rate be? 
• What are the key market trends? 
• What is driving this market? 
• What are the challenges to market growth? 
• Who are the key vendors in this market space? 
• What are the market opportunities and threats faced by the key vendors? 
• What are the strengths and weaknesses of the key vendors?

 

Complete Report Details @ https://www.wiseguyreports.com/reports/1563884-global-castration-resistant-prostate-cancer-treatment-market-2017-2021

 

Table of Contents -Major Key Points

PART 01: Executive summary 

PART 02: Scope of the report 

PART 03: Research Methodology 

PART 04: Introduction 
• Market outline 
• CRPC 

PART 05: Market landscape 
• Market overview 
• Market size and forecast 
• Five forces analysis 

PART 06: Pipeline landscape 

PART 07: Market segmentation by therapy 
• Hormonal therapy 
• Chemotherapy 
• Others 

PART 08: Geographical segmentation 
• CRPC treatment market in Americas 
• CRPC treatment market in EMEA 
• CRPC market in APAC 

PART 09: Decision framework 

PART 10: Drivers and challenges 
• Market drivers 
• Market challenges 

PART 11: Market trends 
• Increasing consolidation in cancer treatment market 
• Emergence of targeted therapies and immunotherapies 

PART 12: Vendor landscape 
• Competitive landscape 

PART 13: Key vendor analysis 
• Astellas Pharma 
• Johnson & Johnson 
• Sanofi 
• Valeant 
• Other prominent vendors 

………..CONTINUED

 

Media Contact
Company Name: Wiseguyreports.com
Contact Person: Norah Trent
Email: Send Email
Phone: +1 646 845 9349, +44 208 133 9349
City: Pune
State: Maharashtra
Country: India
Website: www.wiseguyreports.com